These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7648647)

  • 1. Nifedipine in ischemic heart disease.
    Kloner RA
    Circulation; 1995 Sep; 92(5):1074-8. PubMed ID: 7648647
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?
    Yusuf S
    Circulation; 1995 Sep; 92(5):1079-82. PubMed ID: 7648648
    [No Abstract]   [Full Text] [Related]  

  • 3. Nifedipine and mortality. Grave defects in the dossier.
    Opie LH; Messerli FH
    Circulation; 1995 Sep; 92(5):1068-73. PubMed ID: 7648646
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium blockers and risk of myocardial infarction and coronary heart disease mortality.
    Mehta JL; Subramanian VB
    Circulation; 1996 Apr; 93(7):1472; author reply 1473. PubMed ID: 8641039
    [No Abstract]   [Full Text] [Related]  

  • 5. Nifedipine in patients with heart disease.
    Phillips RA; Krakoff LR
    Circulation; 1996 Apr; 93(7):1474-5. PubMed ID: 8641043
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrections to the nifedipine meta-analysis.
    Furberg CD; Psaty BM
    Circulation; 1996 Apr; 93(7):1475-6. PubMed ID: 8641044
    [No Abstract]   [Full Text] [Related]  

  • 7. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.
    Furberg CD; Psaty BM; Meyer JV
    Circulation; 1995 Sep; 92(5):1326-31. PubMed ID: 7648682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and benefits of calcium antagonists.
    Lichtlen PR
    Lancet; 1995 Oct; 346(8980):962. PubMed ID: 7564741
    [No Abstract]   [Full Text] [Related]  

  • 9. Nifedipine Gastrointestinal Therapeutic System (GITS) in the treatment of coronary heart disease and hypertension.
    Kragten JA; Dunselman PH
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):643-53. PubMed ID: 17605643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nifedipine in acute coronary syndromes: Furberg's refrain revisited.
    Rafflenbeul W
    Eur Heart J; 1996 Aug; 17(8):1147-52. PubMed ID: 8869854
    [No Abstract]   [Full Text] [Related]  

  • 11. Nifedipine trials.
    Rafflenbeul W
    Circulation; 1996 Apr; 93(7):1473-4. PubMed ID: 8641042
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment with nifedipine retard: increasing doses as a therapeutic method].
    Lobos Berajano JM; Lahoz Rallo F; Seguido Aliaga P; Castellanos Maroto J; Robles Pérez R
    Rev Clin Esp; 1989 Jan; 184(1):47-9. PubMed ID: 2704870
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of a slow-release nifedipine on 24-hour ambulatory blood pressure and ischemic changes on 24-hour ambulatory electrocardiogram in patients with severe coronary artery disease.
    Matsumoto N; Ideishi M; Sasaguri M; Nii T; Nakashima Y; Arakawa K
    Cardiology; 2000; 94(1):36-43. PubMed ID: 11111143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium channel blockers pharmacology and their use as tocolytics].
    Bejan-Angoulvant T; Crochet J; Jonville-Bera AP
    J Gynecol Obstet Biol Reprod (Paris); 2015 Apr; 44(4):305-11. PubMed ID: 25728783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-substitution of nifedipine slow-release preparations.
    Van Veenhuyzen D; Coetzee R
    S Afr Med J; 2002 Nov; 92(11):838, 840. PubMed ID: 12506575
    [No Abstract]   [Full Text] [Related]  

  • 16. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
    Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
    Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic differences between nifedipine capsule and GITS formulations in hypertensive patients.
    Isordia I; Carrasco M; Chávez-Negrete A; Palma-Aguirre JA; Flores-Murrieta FJ; Castañeda-Hernández G
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):133. PubMed ID: 9089004
    [No Abstract]   [Full Text] [Related]  

  • 18. Nifedipine study.
    Lichtlen PR
    Circulation; 1996 Apr; 93(7):1472; author reply 1473. PubMed ID: 8641040
    [No Abstract]   [Full Text] [Related]  

  • 19. Nifedipine XL-induced dysuria.
    Patil K; Tabibian JH; Lake M; Sisson S
    Am J Med; 2012 Sep; 125(9):e3-4. PubMed ID: 22682792
    [No Abstract]   [Full Text] [Related]  

  • 20. [Nifedipine in ischemic heart disease: a ban on its use or a differential approach to therapy?].
    Martsevich SIu
    Ter Arkh; 1996; 68(9):31-5. PubMed ID: 9005608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.